Towards new business models for R&D for novel antibiotics


So, AD; Gupta, N; Brahmachari, SK; Chopra, I; Munos, B; Nathan, C; Outterson, K; Paccaud, JP; Payne, DJ; Peeling, RW; Spigelman, M; Weigelt, J; (2011) Towards new business models for R&D for novel antibiotics. Drug resistance updates, 14 (2). pp. 88-94. ISSN 1368-7646 DOI: https://doi.org/10.1016/j.drup.2011.01.006

Full text not available from this repository.

Abstract

In the face of a growing global burden of resistance to existing antibiotics, a combination of scientific and economic challenges has posed significant barriers to the development of novel antibacterials over the past few decades. Yet the bottlenecks at each stage of the pharmaceutical value chain from discovery to post-marketing present opportunities to reengineer an innovation pipeline that has fallen short. The upstream hurdles to lead identification and optimization may be eased with greater multi-sectoral collaboration, a growing array of alternatives to high-throughput screening, and the application of open source approaches. Product development partnerships and South-South innovation platforms have shown promise in bolstering the R&D efforts to tackle neglected diseases. Strategies that delink product sales from the firms' return on investment can help ensure that the twin goals of innovation and access are met. To effect these changes, both public and private sector stakeholders must show greater commitment to an R&D agenda that will address this problem, not only for industrialized countries but also globally. (C) 2011 Elsevier Ltd. All rights reserved.

Item Type: Article
Keywords: Antibiotics, Resistance, Pharmaceutical innovation, Drug development, Value chain, DISCOVERY, DRUGS, SUCCESS
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID: 21439891
Web of Science ID: 291375900005
URI: http://researchonline.lshtm.ac.uk/id/eprint/538

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
298Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item